Crystallin, alpha B (CRYAB) (N-Term) Peptide
Quick Overview for Crystallin, alpha B (CRYAB) (N-Term) Peptide (ABIN975335)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- RPFFPFHSPS RLFDQFFGEH LLESDLFSTA TSLSPFYLRP PSFLRAPSWI
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Cryab Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CRYAB (Crystallin, alpha B (CRYAB))
-
Background
-
Cryab is a structural constituent of the lens that may have non-ocular functions as well, it may play a role in response to cardiac stress during ischemia.
Alias Symbols: AACRYA
Protein Interaction Partner: Hspb6
Protein Size: 175 -
Molecular Weight
- 19 kDa
-
Gene ID
- 25420
-
NCBI Accession
- NM_012935, NP_037067
-
UniProt
- P23928
Target
-